As leader of the IHS consulting team, Marieke focuses on developing robotics beyond the device itself. She and her team partner with hospitals on the design, development and delivery of robotic programs to help them achieve their strategic objectives. The ultimate goal: help hospitals realize more value from their robot purchase through optimization of patient care and standardization around patient treatment.
Technology is evolving rapidly with many new surgical innovations, but we have to continually ask ourselves–why this specific technology? How is it going to benefit the end user? What’s important is that technology enables us as surgeons to do things better for our patients.
We’ve spoken to thought leaders from around the world to capture diverse perspectives on everything related to robotic-assisted surgery (RAS): from various training methodologies and the fundamentals of program success to overcoming challenges, setting new standards and preparing for the future.
The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In the EU, the Hugo™ RAS system is CE marked. In the U.S., the Hugo™ system is an investigational device not for sale. Touch Surgery™ Ecosystem is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition.